EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Compensatory Masseteric Bulging: A Novel Observation and Its Implications for Botulinum Neurotoxin Injection Techniques

Kyu-Ho Yi iD, Jovian Wan

Journal of Cosmetic Dermatology · 2025

DOI: 10.1111/jocd.70090 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Kyu-Ho Yi und 1 weiteren Autor:innen. Beteiligte Einrichtung: You and I Clinic, Seoul, Korea. Hauptthemen laut MEDLINE: Masseter Muscle, Botulinum Toxins, Type A, Neuromuscular Agents, Cosmetic Techniques. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Compensatory masseteric bulging, a newly identified complication, arises from repeated botulinum neurotoxin injections targeting the lower mid‐masseter in East Asians. This phenomenon occurs when untreated upper muscle layers hypertrophy to compensate for weakened lower regions, disrupting facial symmetry. Traditional injection strategies, focused on the lower muscle bulk, overlook the masseter's complex three‐layered anatomy (superficial, middle, deep), increasing asymmetry risks.

Methods

To prevent compensatory bulging, a retrograde, layered injection technique is proposed, distributing botulinum neurotoxin evenly across the upper, middle, and lower masseter. Ultrasound guidance enhances precision, ensuring toxin delivery to targeted layers while avoiding diffusion into adjacent muscles (e.g., risorius). Personalized dosing, adjusted for muscle thickness, activity, and treatment history, minimizes localized over‐atrophy.

Results

A 34‐year‐old female developed upper masseter bulging after four lower mid‐masseter botulinum toxin sessions over two years. Ultrasound revealed upper hypoechoic hypertrophy (12 mm thickness) contrasting with lower hyperechoic atrophy (5 mm). Injecting 50 units of LetibotulinumtoxinA into the upper masseter reduced hypertrophy (8 mm post‐treatment), restoring facial symmetry.

Discussion

Compensatory bulging underscores the need for holistic treatment addressing the entire muscle. Layered injections, guided by ultrasound and tailored dosing, mitigate asymmetry risks. Clinicians must adopt comprehensive strategies, integrating anatomical insights and advanced imaging, to optimize aesthetic outcomes in masseter hypertrophy management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Masseter MuscleBotulinum Toxins, Type ANeuromuscular AgentsCosmetic TechniquesHumansFemaleAdultInjections, IntramuscularHypertrophyUltrasonography, Interventional

Substanzen

Botulinum Toxins, Type ANeuromuscular Agents

Autor:innen und Institutionen

  • You and I Clinic, Seoul, Korea.
  • Division in Anatomy and Developmental Biology, Department of Oral Biology, Human Identification Research Institute, BK21 FOUR Project, Yonsei University College of Dentistry, Seoul, Korea.
  • Medical Research Inc., Wonju, South Korea.

ORCID-Profile: Kyu-Ho Yi

Zitieren

APA

Yi, K. H., & Wan, J. (2025). Compensatory Masseteric Bulging: A Novel Observation and Its Implications for Botulinum Neurotoxin Injection Techniques. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70090

Vancouver

Yi KH, Wan J. Compensatory Masseteric Bulging: A Novel Observation and Its Implications for Botulinum Neurotoxin Injection Techniques. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70090

BibTeX
@article{Yi2025,
  author = {Yi, Kyu-Ho and Wan, Jovian},
  title = {Compensatory Masseteric Bulging: A Novel Observation and Its Implications for Botulinum Neurotoxin Injection Techniques},
  journal = {Journal of Cosmetic Dermatology},
  year = {2025},
  doi = {10.1111/jocd.70090}
}
Kostenlos starten →